CWIAX
Price
$74.39
Change
+$0.31 (+0.42%)
Updated
Sep 26 closing price
Net Assets
140.16B
LGCRX
Price
$19.48
Change
+$0.11 (+0.57%)
Updated
Sep 26 closing price
Net Assets
307.72M
Interact to see
Advertisement

CWIAX vs LGCRX

Header iconCWIAX vs LGCRX Comparison
Open Charts CWIAX vs LGCRXBanner chart's image
American Funds Capital World Gr&Inc 529A
Price$74.39
Change+$0.31 (+0.42%)
VolumeN/A
Net Assets140.16B
Lord Abbett Global Equity R3
Price$19.48
Change+$0.11 (+0.57%)
VolumeN/A
Net Assets307.72M
CWIAX vs LGCRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
CWIAX vs. LGCRX commentary
Sep 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWIAX is a Buy and LGCRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWIAX has more cash in the bank: 140B vs. LGCRX (308M). CWIAX pays higher dividends than LGCRX: CWIAX (1.43) vs LGCRX (0.14). CWIAX was incepted earlier than LGCRX: CWIAX (24 years) vs LGCRX (9 years). LGCRX (1.97) is less costly to investors than CWIAX (0.78). LGCRX is a more actively managed with annual turnover of: 41.00 vs. CWIAX (27.00). LGCRX has a lower initial minimum investment than CWIAX: LGCRX (0) vs CWIAX (250). LGCRX annual gain was more profitable for investors over the last year : 16.34 vs. CWIAX (9.41). LGCRX (61.24) and CWIAX (58.49) have equivalent 5 years return.
CWIAXLGCRXCWIAX / LGCRX
Total Expense Ratio0.781.1568%
Annual Report Gross Expense Ratio0.781.9740%
Fund Existence24 years9 years-
Gain YTD18.85617.918105%
Front Load4%N/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets140B308M45,455%
Annual Yield % from dividends1.430.141,018%
Returns for 1 year9.4116.3458%
Returns for 3 years70.7982.7886%
Returns for 5 years58.4961.2496%
Returns for 10 years114.38N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RXRX4.720.09
+1.94%
Recursion Pharmaceuticals
LITE160.751.64
+1.03%
Lumentum Holdings
PTLO6.320.02
+0.32%
Portillo's
CAPN10.47N/A
N/A
Cayson Acquisition Corp
SCNI1.32-0.02
-1.49%
Scinai Immunotherapeutics Ltd.